Woodline Partners’s Trillium Therapeutics Inc. TRIL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-139,907
| Closed | -$2.46M | – | 862 |
|
|
2021
Q3 | $2.46M | Sell |
139,907
-1,726,166
| -93% | -$30.3M | 0.04% | 376 |
|
|
2021
Q2 | $18.1M | Buy |
1,866,073
+831,082
| +80% | +$8.06M | 0.34% | 78 |
|
|
2021
Q1 | $11.1M | Buy |
1,034,991
+273,526
| +36% | +$2.94M | 0.25% | 103 |
|
|
2020
Q4 | $11.2M | Sell |
761,465
-69,032
| -8% | -$1.02M | 0.3% | 101 |
|
|
2020
Q3 | $11.8M | Buy |
830,497
+203,687
| +32% | +$2.89M | 0.39% | 79 |
|
|
2020
Q2 | $5.07M | Sell |
626,810
-27,971
| -4% | -$226K | 0.2% | 113 |
|
|
2020
Q1 | $2.65M | Buy |
+654,781
| New | +$2.65M | 0.19% | 110 |
|